How to use the speech recognition tool?

NCT01756456

REPARO

Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2013-05-23
  • Closing Date: 2015-03-06

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Anterior Segment Rare Eye Diseases (WG4)

Subscribe to our mailing list

* indicates required

This ERN is supported by: